These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 6279682

  • 1. Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture.
    Proper JA, Bjornson CL, Moses HL.
    J Cell Physiol; 1982 Feb; 110(2):169-74. PubMed ID: 6279682
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor production by chemically transformed cells.
    Moses HL, Branum EL, Proper JA, Robinson RA.
    Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factors in solid human malignant neoplasms.
    Nickell KA, Halper J, Moses HL.
    Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535
    [Abstract] [Full Text] [Related]

  • 4. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF, Volkenant ME, Branum EL, Moses HL.
    Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.
    van Zoelen EJ, van Oostwaard TM, van der Saag PT, de Laat SW.
    J Cell Physiol; 1985 May; 123(2):151-60. PubMed ID: 2984216
    [Abstract] [Full Text] [Related]

  • 6. Purification and characterization of a novel transforming growth factor.
    Halper J, Moses HL.
    Cancer Res; 1987 Sep 01; 47(17):4552-9. PubMed ID: 2887280
    [Abstract] [Full Text] [Related]

  • 7. Epithelial tissue-derived growth factor-like polypeptides.
    Halper J, Moses HL.
    Cancer Res; 1983 May 01; 43(5):1972-9. PubMed ID: 6572559
    [Abstract] [Full Text] [Related]

  • 8. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS, Zwiebel JA, Bano M, Losonczy I, Fehnel P, Kidwell WR.
    Cancer Res; 1984 Sep 01; 44(9):4069-77. PubMed ID: 6331663
    [Abstract] [Full Text] [Related]

  • 9. Elevated growth factor levels in transformed mouse embryo cells treated with N,N-dimethylformamide.
    Levine AE, Hamilton DA, McRae LJ, Brattain MG.
    Cancer Res; 1985 Jan 01; 45(1):108-11. PubMed ID: 2981156
    [Abstract] [Full Text] [Related]

  • 10. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK, Lynch KE, Podolsky DK.
    Cancer Res; 1988 Apr 01; 48(7):1792-7. PubMed ID: 2894891
    [Abstract] [Full Text] [Related]

  • 11. Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell line.
    Hirai R, Yamaoka K, Mitsui H.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):5742-6. PubMed ID: 6315215
    [Abstract] [Full Text] [Related]

  • 12. Partial purification and characterization of a hepatocyte growth factor produced by rat hepatocellular carcinoma cells.
    Luetteke NC, Michalopoulos GK.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6331-7. PubMed ID: 2998598
    [Abstract] [Full Text] [Related]

  • 13. Normal embryo fibroblasts release transforming growth factors in a latent form.
    Lawrence DA, Pircher R, Krycève-Martinerie C, Jullien P.
    J Cell Physiol; 1984 Oct 01; 121(1):184-8. PubMed ID: 6090474
    [Abstract] [Full Text] [Related]

  • 14. Anchorage-independent growth-conferring factor production by rat mammary tumor cells.
    Zwiebel JA, Davis MR, Kohn E, Salomon DS, Kidwell WR.
    Cancer Res; 1982 Dec 01; 42(12):5117-25. PubMed ID: 6291748
    [Abstract] [Full Text] [Related]

  • 15. The purification of an acid- and heat-labile transforming growth factor from an avian sarcoma virus-transformed rat cell line.
    Yamaoka K, Hirai R, Tsugita A, Mitsui H.
    J Cell Physiol; 1984 Jun 01; 119(3):307-14. PubMed ID: 6327732
    [Abstract] [Full Text] [Related]

  • 16. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA, Branum EL, Volkenant ME, Moses HL.
    Cancer Res; 1982 Jul 01; 42(7):2633-8. PubMed ID: 6979383
    [Abstract] [Full Text] [Related]

  • 17. Partial purification of transforming growth factors from human milk.
    Zwiebel JA, Bano M, Nexo E, Salomon DS, Kidwell WR.
    Cancer Res; 1986 Feb 01; 46(2):933-9. PubMed ID: 3000589
    [Abstract] [Full Text] [Related]

  • 18. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts.
    Pietenpol JA, Howe PH, Cunningham MR, Leof EB.
    J Cell Physiol; 1989 Dec 01; 141(3):453-60. PubMed ID: 2687295
    [Abstract] [Full Text] [Related]

  • 19. Mouse embryonic transforming growth factors related to those isolated from tumor cells.
    Twardzik DR, Ranchalis JE, Todaro GJ.
    Cancer Res; 1982 Feb 01; 42(2):590-3. PubMed ID: 6275982
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factors released from Kirsten sarcoma virus transformed cells do not compete for epidermal growth factor membrane receptors.
    Chua CC, Geiman D, Ladda RL.
    J Cell Physiol; 1983 Oct 01; 117(1):116-22. PubMed ID: 6311845
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.